Reply to Roemer and Guermazi: Early biochemical changes on MRI can predict risk of symptomatic progression

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

  • Shinjini Kundu
  • Beth G Ashinsky
  • Mustapha Bouhrara
  • Dam, Erik Bjørnager
  • Shadpour Demehri
  • M Shifat-E-Rabbi
  • Richard G Spencer
  • Kenneth L Urish
  • Gustavo K Rohde
OriginalsprogEngelsk
Artikelnummere2024679118
TidsskriftProceedings of the National Academy of Sciences of the United States of America
Vol/bind118
Udgave nummer11
Antal sider2
ISSN0027-8424
DOI
StatusUdgivet - 2021

ID: 260294672